Clinical Aspects and Genetics of Cardiomyopathies
作者： Aris Anastasakis
DOI: 10.1007/978-3-319-08798-6_25
关键词: Biology 、 Coronary artery disease 、 Internal medicine 、 Cardiology 、 Cardiomyopathy 、 Heart failure 、 Treatment options 、 Myocardial Disorder 、 Sudden death 、 Stroke 、 Pathology 、 Clinical events
摘要: Cardiomyopathies (CMP) are myocardial disorders that not explained by abnormal loading conditions and coronary artery disease. They classified into a number of morphological functional phenotypes can be caused genetic non-genetic mechanisms. Despite considerable heterogeneity within the categories hypertrophic, dilated, restrictive, arrhythmogenic right ventricular, other types CMP, these diagnostic classifications predict major complications delineate treatment options for each group. Recently, we face development more sophisticated methods, including evaluation, predicting adverse clinical events.
springer.com
sci-hub.st 参考文章(99)
Paolo Spirito, Camillo Autore, Claudio Rapezzi, Paola Bernabò, Roberto Badagliacca, Martin S. Maron, Sergio Bongioanni, Fabio Coccolo, N.A. Mark Estes, Caterina S. Barillà, Elena Biagini, Giovanni Quarta, Maria Rosa Conte, Paolo Bruzzi, Barry J. Maron, Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation. ,vol. 119, pp. 1703- 1710 ,(2009) , 10.1161/CIRCULATIONAHA.108.798314
A Anastasakis, C Kotsiopoulou, A Rigopoulos, A Theopistou, N Protonotarios, D Panagiotakos, N Mammalis, C Stefanadis, Similarities in the profile of cardiopulmonary exercise testing between patients with hypertrophic cardiomyopathy and strength athletes Heart. ,vol. 91, pp. 1477- 1478 ,(2005) , 10.1136/HRT.2004.055053
Michael A. Fifer, Gus J. Vlahakes, Management of Symptoms in Hypertrophic Cardiomyopathy Circulation. ,vol. 117, pp. 429- 439 ,(2008) , 10.1161/CIRCULATIONAHA.107.694158
Lorenzo Monserrat, Perry M Elliott, Juan R Gimeno, Sanjay Sharma, Manuel Penas-Lado, William J McKenna, Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients Journal of the American College of Cardiology. ,vol. 42, pp. 873- 879 ,(2003) , 10.1016/S0735-1097(03)00827-1
Perry Elliott, Robert Baker, Ferdinando Pasquale, Giovanni Quarta, Hatim Ebrahim, Atul B Mehta, Derralynn A Hughes, None, Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey Heart. ,vol. 97, pp. 1957- 1960 ,(2011) , 10.1136/HEARTJNL-2011-300364
W J McKenna, J E Deanfield, Hypertrophic cardiomyopathy: an important cause of sudden death. Archives of Disease in Childhood. ,vol. 59, pp. 971- 975 ,(1984) , 10.1136/ADC.59.10.971
Barry J Maron, William C Roberts, Michael Arad, Tammy S Haas, Paolo Spirito, Gregory B Wright, Adrian K Almquist, Jeanne M Baffa, J Philip Saul, Carolyn Y Ho, Jonathan Seidman, Christine E Seidman, Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy JAMA. ,vol. 301, pp. 1253- 1259 ,(2009) , 10.1001/JAMA.2009.371
C. O'Mahony, F. Jichi, M. Pavlou, L. Monserrat, A. Anastasakis, C. Rapezzi, E. Biagini, J. R. Gimeno, G. Limongelli, W. J. McKenna, R. Z. Omar, P. M. Elliott, , A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD) European Heart Journal. ,vol. 35, pp. 2010- 2020 ,(2014) , 10.1093/EURHEARTJ/EHT439
D. Jacoby, W. J. McKenna, Genetics of inherited cardiomyopathy European Heart Journal. ,vol. 33, pp. 296- 304 ,(2012) , 10.1093/EURHEARTJ/EHR260
Franco Cecchi, Iacopo Olivotto, Roberto Gistri, Roberto Lorenzoni, Giampaolo Chiriatti, Paolo G. Camici, Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy New England Journal of Medicine. ,vol. 349, pp. 1027- 1035 ,(2003) , 10.1056/NEJMOA025050